Polaris Quantum Biotech on OurCrowd 2022

Polaris Quantum Biotech, with a valuation of $40 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company uses the latest innovations in cloud and quantum computing, artificial intelligence, and machine learning to develop new drugs in a fraction of the time and cost of conventional methods. The platform and technology of Polaris Quantum Biotech scan billions of molecules from a large chemical space to find the molecules most suitable for drug development. Dr. Shahar Keinan and Bill Shipman founded Polaris Quantum Biotech in 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,120,000. The campaign proceeds will be used for growth and expansion.